Vigilant Biosciences, Inc.
Vigilant Biosciences is a leading innovator and developer of solutions that aid in the early detection and intervention of cancer. Our mission is to enhance the lives of patients and their families by providing transformative products that raise awareness of and enable early cancer intervention.
Our point-of-care and lab-based solutions are simple, accurate and cost-effective—empowering healthcare practitioners with an aid in the diagnosis of oral cancer and improving outcomes through earlier intervention.
Vigilant Biosciences™ products are based on patented technology that detects specific protein markers clinically shown to be associated with early stage cancers, even prior to observation of visual or physical symptoms. The OncAlert™ Oral Cancer LAB Test and OncAlert™ Oral Cancer RAPID Test are both CE Marked and available in select international markets.